Chestnut Hill, MA, United States of America

Gerassimos Makrigiorgos

This inventor holds 1 USPTO granted patent and 8 published patent applications, plus 5 CIPO patents and 6 EPO patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerassimos Makrigiorgos. Retrieved from https://idiyas.com/inventor/gerassimos-makrigiorgos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerassimos Makrigiorgos: Innovator in DNA Mutation Testing

Introduction

Gerassimos Makrigiorgos is a prominent inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of DNA mutation testing. His innovative approaches have the potential to enhance the efficiency of genetic analysis.

Latest Patents

Gerassimos holds a patent for "Denaturation-enhanced DNA mutation testing for limited biological specimens." This patent discloses methods aimed at improving the efficiency of absolute quantification of nucleic acid targets, such as digital PCR and digital isothermal amplification. It also addresses the reduction of nucleic acid sample requirements necessary to determine the absolute quantity of target sequences in a sample. He has 1 patent to his name.

Career Highlights

Gerassimos is affiliated with the Dana-Farber Cancer Institute Inc., where he applies his expertise in cancer research and molecular diagnostics. His work is instrumental in advancing the understanding of genetic mutations and their implications in cancer.

Collaborations

Some of his notable coworkers include Cloud P. Paweletz and Chen Song, who collaborate with him on various research projects aimed at improving cancer diagnostics.

Conclusion

Gerassimos Makrigiorgos is a key figure in the field of DNA mutation testing, with a focus on enhancing the efficiency of genetic analysis. His contributions are paving the way for advancements in cancer research and diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…